BIO-TECHNE Corp - COMMON STOCK (TECH) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
TECH on Nasdaq
Shares outstanding
152,309,909
Price per share
$58.81
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
158,868,891
Total reported value
$8,836,919,978
% of total 13F portfolios
0.01%
Share change
+412,368
Value change
+$43,761,942
Number of holders
563
Price from insider filings
$58.81
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-TECHNE Corp - COMMON STOCK (TECH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $566,544,556 11,011,556 BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -57% $186,406,005 -$305,816,579 3,350,818 -62% T. Rowe Price Associates, Inc. 30 Sep 2025

As of 30 Sep 2025, 563 institutional investors reported holding 158,868,891 shares of BIO-TECHNE Corp - COMMON STOCK (TECH). This represents 104% of the company’s total 152,309,909 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIO-TECHNE Corp - COMMON STOCK (TECH) together control 65% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 17,932,373 -2.7% 0.01% $997,577,910
BlackRock, Inc. 7.8% 11,887,082 -2.3% 0.01% $661,278,402
MORGAN STANLEY 4.8% 7,237,877 +10% 0.02% $402,643,221
STATE STREET CORP 3.8% 5,753,393 -1.8% 0.01% $320,061,253
WELLINGTON MANAGEMENT GROUP LLP 3.4% 5,115,133 +350% 0.05% $284,554,850
GEODE CAPITAL MANAGEMENT, LLC 3.2% 4,927,178 +21% 0.02% $273,678,698
Invesco Ltd. 2.6% 3,946,028 +7.7% 0.03% $219,517,538
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% 3,350,144 -62% 0.02% $186,370,000
NEUBERGER BERMAN GROUP LLC 2.2% 3,307,116 +32% 0.13% $183,974,851
MAVERICK CAPITAL LTD 2% 3,012,654 2.2% $167,593,942
AMERIPRISE FINANCIAL INC 1.8% 2,815,161 -18% 0.04% $156,607,476
MAIRS & POWER INC 1.8% 2,807,409 +3.4% 1.5% $156,176,151
DF DENT & CO INC 1.8% 2,780,961 +2.1% 2% $154,704,870
MACKENZIE FINANCIAL CORP 1.7% 2,559,590 -2.3% 0.17% $142,389,992
BAMCO INC /NY/ 1.6% 2,496,323 -11% 0.37% $138,870,448
Sumitomo Mitsui Trust Group, Inc. 1.5% 2,355,618 +0.25% 0.08% $131,043,029
RGM Capital, LLC 1.5% 2,300,052 +4.5% 5.4% $127,951,893
Select Equity Group, L.P. 1.5% 2,251,593 -23% 0.54% $125,256,119
AMERICAN CENTURY COMPANIES INC 1.3% 2,037,806 +78% 0.06% $113,363,148
Bank of New York Mellon Corp 1.3% 1,930,042 +0.36% 0.02% $107,368,284
BROWN ADVISORY INC 1.2% 1,865,601 +5.1% 0.14% $103,783,384
MACQUARIE GROUP LTD 1.2% 1,830,994 +1.9% 0.12% $101,858,366
SNYDER CAPITAL MANAGEMENT L P 1.1% 1,719,135 +29% 1.8% $95,635,480
DIMENSIONAL FUND ADVISORS LP 1.1% 1,710,513 +3% 0.02% $95,129,036
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.1% 1,709,662 +76% 0.25% $95,108,497

Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 330,127 $19,553,115 +$7,448,756 $58.81 26
2025 Q3 158,868,891 $8,836,919,978 +$43,761,942 $55.63 563
2025 Q2 158,628,992 $8,162,083,726 -$121,661,613 $51.45 549
2025 Q1 160,482,754 $9,405,648,682 +$179,026,718 $58.63 570
2024 Q4 156,683,809 $11,287,230,171 +$66,773,071 $72.03 570
2024 Q3 154,600,456 $12,351,604,330 +$7,433,196 $79.93 556
2024 Q2 155,869,664 $11,167,617,679 -$177,733,977 $71.65 567
2024 Q1 158,523,717 $11,156,213,905 +$202,103,671 $70.39 546
2023 Q4 155,453,274 $11,990,770,023 +$252,157,462 $77.16 525
2023 Q3 152,193,816 $10,358,362,931 +$40,449,398 $68.07 522
2023 Q2 151,139,522 $12,331,718,195 +$212,796,041 $81.63 521
2023 Q1 148,715,946 $11,031,044,107 -$125,004,989 $74.19 542
2022 Q4 150,382,048 $12,465,020,754 +$9,251,047,940 $82.88 536
2022 Q3 38,142,242 $10,837,756,102 +$194,266,932 $284.00 520
2022 Q2 37,209,172 $12,897,621,890 -$179,595,754 $346.64 534
2022 Q1 37,711,486 $16,331,488,594 +$324,651,170 $433.04 546
2021 Q4 36,855,059 $19,055,177,448 -$21,586,911 $517.34 560
2021 Q3 36,736,696 $17,797,604,388 +$72,229,932 $484.57 556
2021 Q2 36,589,162 $16,468,259,256 +$203,566,288 $450.26 504
2021 Q1 36,496,866 $13,940,028,921 +$172,769,577 $381.93 460
2020 Q4 36,189,306 $11,493,926,712 -$16,778,721 $317.55 426
2020 Q3 36,254,970 $8,982,485,029 -$42,929,390 $247.73 409
2020 Q2 36,379,136 $9,604,991,764 -$81,539,071 $264.07 384
2020 Q1 36,823,671 $6,987,799,245 +$119,012,127 $189.62 357
2019 Q4 35,776,726 $7,852,981,745 -$46,029,404 $219.51 366
2019 Q3 35,990,901 $7,043,547,397 +$117,132,644 $195.67 333
2019 Q2 35,416,061 $7,383,307,878 +$61,945,595 $208.49 362
2019 Q1 35,546,314 $7,057,725,860 +$61,379,403 $198.55 347
2018 Q4 35,371,213 $5,119,061,152 -$122,869,763 $144.72 316
2018 Q3 35,826,309 $7,311,255,210 +$15,680,998 $204.11 335
2018 Q2 35,998,975 $5,325,911,858 +$35,737,877 $147.95 333
2018 Q1 35,891,582 $5,420,812,522 -$28,478,791 $151.04 325
2017 Q4 36,357,570 $4,710,259,737 -$46,673,008 $129.55 288
2017 Q3 36,860,326 $4,455,237,647 -$52,528,460 $120.89 282
2017 Q2 37,300,606 $4,382,632,640 +$214,841,252 $117.50 272
2017 Q1 36,529,302 $3,713,044,239 +$392,401,939 $101.65 265
2016 Q4 35,943,908 $3,695,994,947 +$12,675,458 $102.83 270
2016 Q3 35,799,364 $3,917,777,202 -$132,633,733 $109.50 279
2016 Q2 37,060,472 $4,178,830,306 -$54,302,334 $112.77 278
2016 Q1 37,564,549 $3,550,310,945 +$20,269,808 $94.52 251
2015 Q4 37,359,133 $3,362,530,330 +$85,876,184 $90.00 258
2015 Q3 36,302,435 $3,356,422,402 -$28,590,696 $92.46 245
2015 Q2 36,725,188 $3,616,194,794 +$4,045,129 $98.47 238
2015 Q1 36,495,519 $3,659,215,883 +$67,728,039 $100.29 243
2014 Q4 36,050,484 $3,331,456,988 +$2,869,117,238 $92.40 252
2014 Q3 4,950,723 $463,140,000 +$463,140,000 $93.55 24